⚕ GalenOps CRO console
← 703 (USA)

703-1086

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 703 (USA) (Dr. Okafor) · consented 2012-09-02
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 12.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 12.0); relationship: PROBABLE

severe assessed 2026-08-18

Severe APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 12.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2012-09-13 (study day 12.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild CHILLS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-10-09 (study day 38.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild CHILLS — outcome: RECOVERED/RESOLVED; onset 2012-10-09 (study day 38.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.